IL17A and bone neoplasm: Furthermore, TLSJ was deemed valid in alleviating bone cancer-induced mechanical allodynia and thermal hyperalgesia by downregulating transient receptor potential channel expression in lumbar dorsal root ganglia and lumbar spinal cord interleukin-17A (IL-17A) in spinal astrocytes [56].